Medha N. Munshi, M.B.,B.S., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypoglycemia | 18 | 2023 | 861 | 5.530 |
Why?
|
Diabetes Mellitus, Type 1 | 13 | 2023 | 3338 | 2.900 |
Why?
|
Blood Glucose | 28 | 2023 | 6254 | 2.580 |
Why?
|
Blood Glucose Self-Monitoring | 14 | 2023 | 434 | 2.530 |
Why?
|
Diabetes Mellitus, Type 2 | 37 | 2024 | 11726 | 2.400 |
Why?
|
Diabetes Mellitus | 16 | 2023 | 5749 | 2.350 |
Why?
|
Hypoglycemic Agents | 25 | 2023 | 2873 | 2.220 |
Why?
|
Insulin | 11 | 2022 | 6582 | 1.170 |
Why?
|
Aging | 9 | 2022 | 8664 | 1.100 |
Why?
|
Diabetes Complications | 6 | 2022 | 1359 | 0.970 |
Why?
|
Long-Term Care | 3 | 2020 | 607 | 0.910 |
Why?
|
Self Care | 6 | 2023 | 786 | 0.880 |
Why?
|
Hyperglycemia | 5 | 2017 | 1373 | 0.700 |
Why?
|
Frail Elderly | 4 | 2022 | 693 | 0.680 |
Why?
|
Health Services for the Aged | 2 | 2018 | 269 | 0.670 |
Why?
|
Postprandial Period | 1 | 2019 | 292 | 0.620 |
Why?
|
Aged | 48 | 2023 | 163288 | 0.610 |
Why?
|
Social Isolation | 1 | 2020 | 365 | 0.600 |
Why?
|
Aged, 80 and over | 27 | 2023 | 57776 | 0.590 |
Why?
|
Skilled Nursing Facilities | 2 | 2020 | 372 | 0.550 |
Why?
|
Insulin Infusion Systems | 3 | 2023 | 212 | 0.540 |
Why?
|
Injections | 1 | 2019 | 840 | 0.540 |
Why?
|
Telemedicine | 2 | 2023 | 2872 | 0.480 |
Why?
|
Health Literacy | 1 | 2019 | 414 | 0.480 |
Why?
|
Evidence-Based Practice | 1 | 2018 | 501 | 0.480 |
Why?
|
Pandemics | 4 | 2023 | 8385 | 0.470 |
Why?
|
Patient-Centered Care | 2 | 2020 | 1438 | 0.450 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3135 | 0.420 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3242 | 0.420 |
Why?
|
Disease Management | 4 | 2018 | 2460 | 0.390 |
Why?
|
Sulfonylurea Compounds | 4 | 2023 | 205 | 0.370 |
Why?
|
Technology | 2 | 2024 | 304 | 0.370 |
Why?
|
Medication Adherence | 2 | 2019 | 2063 | 0.350 |
Why?
|
Humans | 70 | 2024 | 744366 | 0.340 |
Why?
|
Adaptation, Physiological | 1 | 2015 | 1312 | 0.330 |
Why?
|
C-Peptide | 2 | 2015 | 419 | 0.330 |
Why?
|
Health Facilities | 1 | 2014 | 572 | 0.330 |
Why?
|
Patient Compliance | 2 | 2015 | 2684 | 0.310 |
Why?
|
Practice Guidelines as Topic | 3 | 2020 | 7282 | 0.310 |
Why?
|
Hypolipidemic Agents | 1 | 2012 | 604 | 0.300 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2219 | 0.300 |
Why?
|
Weight Gain | 1 | 2017 | 2293 | 0.300 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 2 | 2021 | 293 | 0.300 |
Why?
|
Comorbidity | 5 | 2023 | 10388 | 0.260 |
Why?
|
Quality of Life | 8 | 2023 | 12802 | 0.250 |
Why?
|
Dyslipidemias | 1 | 2012 | 849 | 0.250 |
Why?
|
Benchmarking | 2 | 2022 | 1042 | 0.240 |
Why?
|
Executive Function | 1 | 2012 | 1364 | 0.230 |
Why?
|
Cognition Disorders | 2 | 2008 | 4043 | 0.220 |
Why?
|
Nursing Homes | 5 | 2023 | 1036 | 0.210 |
Why?
|
Polypharmacy | 2 | 2019 | 294 | 0.210 |
Why?
|
Geriatric Assessment | 2 | 2020 | 1372 | 0.200 |
Why?
|
Age Factors | 4 | 2020 | 18373 | 0.190 |
Why?
|
Middle Aged | 19 | 2024 | 213390 | 0.180 |
Why?
|
Caregivers | 2 | 2023 | 2095 | 0.180 |
Why?
|
Cognition | 5 | 2023 | 6770 | 0.180 |
Why?
|
Professional Role | 2 | 2015 | 306 | 0.170 |
Why?
|
Drug Administration Schedule | 2 | 2017 | 4933 | 0.170 |
Why?
|
Medicare Part D | 1 | 2023 | 328 | 0.160 |
Why?
|
Drug Combinations | 1 | 2023 | 1958 | 0.160 |
Why?
|
Prevalence | 4 | 2017 | 15221 | 0.160 |
Why?
|
Administration, Oral | 3 | 2017 | 3914 | 0.150 |
Why?
|
Costs and Cost Analysis | 1 | 2023 | 1680 | 0.150 |
Why?
|
New England | 1 | 2020 | 1022 | 0.150 |
Why?
|
Male | 27 | 2024 | 350115 | 0.140 |
Why?
|
Syndrome | 1 | 2023 | 3252 | 0.140 |
Why?
|
Elder Nutritional Physiological Phenomena | 1 | 2015 | 7 | 0.140 |
Why?
|
Female | 29 | 2024 | 380193 | 0.140 |
Why?
|
Patient Education as Topic | 3 | 2015 | 2278 | 0.140 |
Why?
|
Homocysteine | 2 | 1997 | 647 | 0.140 |
Why?
|
Metformin | 1 | 2023 | 836 | 0.130 |
Why?
|
Voluntary Health Agencies | 1 | 1995 | 39 | 0.130 |
Why?
|
Glucose | 3 | 2023 | 4398 | 0.130 |
Why?
|
Resilience, Psychological | 1 | 2022 | 677 | 0.130 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2018 | 10943 | 0.130 |
Why?
|
Depressive Disorder | 1 | 2008 | 3747 | 0.130 |
Why?
|
Vulnerable Populations | 1 | 2020 | 686 | 0.130 |
Why?
|
Health Status Indicators | 1 | 2020 | 970 | 0.120 |
Why?
|
Methionine | 2 | 1997 | 590 | 0.120 |
Why?
|
Didanosine | 1 | 1994 | 153 | 0.120 |
Why?
|
Hyperglycemic Hyperosmolar Nonketotic Coma | 1 | 1994 | 24 | 0.120 |
Why?
|
Life Style | 4 | 2023 | 3835 | 0.120 |
Why?
|
Diabetic Angiopathies | 2 | 1997 | 818 | 0.120 |
Why?
|
Risk | 2 | 2017 | 9688 | 0.120 |
Why?
|
Retrospective Studies | 9 | 2023 | 77460 | 0.120 |
Why?
|
Monitoring, Ambulatory | 1 | 2017 | 355 | 0.120 |
Why?
|
Communicable Disease Control | 1 | 2020 | 856 | 0.110 |
Why?
|
Needs Assessment | 1 | 2019 | 1147 | 0.110 |
Why?
|
Insulin, Long-Acting | 1 | 2013 | 57 | 0.110 |
Why?
|
Prospective Studies | 5 | 2019 | 53290 | 0.110 |
Why?
|
Cardiovascular Diseases | 2 | 2024 | 15160 | 0.110 |
Why?
|
Trail Making Test | 1 | 2012 | 57 | 0.110 |
Why?
|
Pregnancy in Diabetics | 1 | 1994 | 179 | 0.110 |
Why?
|
Patient Care Planning | 1 | 2018 | 921 | 0.110 |
Why?
|
Adult | 11 | 2023 | 214052 | 0.110 |
Why?
|
Hypertension | 2 | 2012 | 8479 | 0.110 |
Why?
|
Obesity, Morbid | 1 | 2023 | 1213 | 0.100 |
Why?
|
Cohort Studies | 4 | 2021 | 40559 | 0.100 |
Why?
|
Peptides | 1 | 2023 | 4410 | 0.100 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 25039 | 0.100 |
Why?
|
Delivery of Health Care | 1 | 2009 | 5321 | 0.090 |
Why?
|
Medical Staff, Hospital | 1 | 1995 | 601 | 0.090 |
Why?
|
Drug Monitoring | 1 | 2017 | 956 | 0.090 |
Why?
|
Myocardial Infarction | 2 | 2022 | 11718 | 0.090 |
Why?
|
Weight Loss | 4 | 2023 | 2625 | 0.090 |
Why?
|
Data Interpretation, Statistical | 1 | 2020 | 2716 | 0.090 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2024 | 2200 | 0.090 |
Why?
|
Psychotherapy, Group | 1 | 2013 | 406 | 0.090 |
Why?
|
Vasodilation | 1 | 2013 | 944 | 0.090 |
Why?
|
Dementia | 1 | 2023 | 2518 | 0.080 |
Why?
|
Endocrinology | 1 | 1995 | 443 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2015 | 2373 | 0.080 |
Why?
|
Physician's Role | 1 | 2015 | 943 | 0.080 |
Why?
|
Follow-Up Studies | 4 | 2017 | 39052 | 0.080 |
Why?
|
HIV Seropositivity | 1 | 1994 | 971 | 0.080 |
Why?
|
Young Adult | 3 | 2019 | 56429 | 0.080 |
Why?
|
United States | 8 | 2023 | 69872 | 0.080 |
Why?
|
Injections, Subcutaneous | 1 | 2009 | 667 | 0.080 |
Why?
|
Depression | 2 | 2020 | 7759 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 9955 | 0.070 |
Why?
|
Age Distribution | 1 | 2013 | 2902 | 0.070 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 6489 | 0.070 |
Why?
|
Sodium | 2 | 2023 | 1622 | 0.070 |
Why?
|
Cost of Illness | 1 | 2015 | 1860 | 0.070 |
Why?
|
Pharmacists | 1 | 2008 | 248 | 0.070 |
Why?
|
Motor Activity | 1 | 2015 | 2715 | 0.070 |
Why?
|
Treatment Outcome | 6 | 2021 | 63107 | 0.060 |
Why?
|
Cell Adhesion Molecules | 1 | 2011 | 1602 | 0.060 |
Why?
|
Cerebrovascular Circulation | 2 | 2013 | 2732 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 3922 | 0.060 |
Why?
|
Risk Factors | 5 | 2020 | 72296 | 0.060 |
Why?
|
Posture | 1 | 2009 | 958 | 0.060 |
Why?
|
Postural Balance | 1 | 2009 | 620 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9312 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8642 | 0.060 |
Why?
|
Medicare | 4 | 2022 | 6566 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5135 | 0.060 |
Why?
|
Glipizide | 1 | 2022 | 47 | 0.050 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2009 | 957 | 0.050 |
Why?
|
Incidence | 2 | 2018 | 20952 | 0.050 |
Why?
|
Regression Analysis | 1 | 2012 | 6459 | 0.050 |
Why?
|
Pregnancy Complications, Infectious | 1 | 1994 | 2026 | 0.050 |
Why?
|
Glyburide | 1 | 2022 | 113 | 0.050 |
Why?
|
Obesity | 2 | 2023 | 12746 | 0.050 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2021 | 88 | 0.050 |
Why?
|
Health Behavior | 1 | 2013 | 2635 | 0.050 |
Why?
|
Overweight | 2 | 2023 | 2371 | 0.050 |
Why?
|
Brain | 3 | 2013 | 26388 | 0.050 |
Why?
|
Stroke | 1 | 2022 | 9981 | 0.040 |
Why?
|
Socioeconomic Factors | 1 | 2014 | 7785 | 0.040 |
Why?
|
Hand Strength | 1 | 2022 | 448 | 0.040 |
Why?
|
Exercise | 3 | 2024 | 5615 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15078 | 0.040 |
Why?
|
Homes for the Aged | 1 | 2021 | 260 | 0.040 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2021 | 340 | 0.040 |
Why?
|
Disabled Persons | 1 | 2008 | 1212 | 0.040 |
Why?
|
Risk Assessment | 1 | 2019 | 23336 | 0.040 |
Why?
|
Models, Biological | 1 | 2014 | 9584 | 0.040 |
Why?
|
Caloric Restriction | 1 | 2020 | 302 | 0.040 |
Why?
|
Diet, Reducing | 1 | 2020 | 462 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2012 | 4369 | 0.040 |
Why?
|
Internship and Residency | 1 | 1995 | 5791 | 0.030 |
Why?
|
Chicago | 1 | 1995 | 240 | 0.030 |
Why?
|
Propensity Score | 1 | 2021 | 1781 | 0.030 |
Why?
|
Entropy | 1 | 2014 | 209 | 0.030 |
Why?
|
Hospitals, University | 1 | 1995 | 570 | 0.030 |
Why?
|
Osteoblasts | 1 | 1998 | 1166 | 0.030 |
Why?
|
Administration, Intranasal | 1 | 2013 | 446 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2021 | 2419 | 0.030 |
Why?
|
Zidovudine | 1 | 1994 | 620 | 0.030 |
Why?
|
Fasting | 1 | 2018 | 1592 | 0.030 |
Why?
|
Medical History Taking | 1 | 1995 | 784 | 0.020 |
Why?
|
Estrogens | 1 | 1998 | 1566 | 0.020 |
Why?
|
Osteogenesis | 1 | 1998 | 1299 | 0.020 |
Why?
|
Adolescent | 1 | 2019 | 85779 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 1998 | 2513 | 0.020 |
Why?
|
Demography | 1 | 1995 | 1655 | 0.020 |
Why?
|
Physical Examination | 1 | 1995 | 1237 | 0.020 |
Why?
|
Consensus | 1 | 2018 | 2960 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1799 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2015 | 21748 | 0.020 |
Why?
|
HIV Infections | 1 | 1994 | 16715 | 0.020 |
Why?
|
Diabetic Retinopathy | 1 | 1996 | 1210 | 0.020 |
Why?
|
Prediabetic State | 1 | 2012 | 499 | 0.020 |
Why?
|
Atrophy | 1 | 2011 | 1584 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12356 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2013 | 1443 | 0.020 |
Why?
|
Oxidative Stress | 1 | 1997 | 3084 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 1994 | 1739 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2018 | 3611 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9145 | 0.020 |
Why?
|
Feedback | 1 | 2009 | 795 | 0.020 |
Why?
|
Stem Cells | 1 | 1998 | 3567 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 1995 | 2212 | 0.020 |
Why?
|
Memory | 1 | 2013 | 2174 | 0.010 |
Why?
|
Time Factors | 2 | 1996 | 40075 | 0.010 |
Why?
|
Smoking Cessation | 1 | 1995 | 2071 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 12721 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2013 | 6994 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2011 | 3778 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2013 | 12025 | 0.010 |
Why?
|
Thiobarbiturates | 1 | 1997 | 5 | 0.010 |
Why?
|
Osteocalcin | 1 | 1998 | 273 | 0.010 |
Why?
|
Free Radicals | 1 | 1997 | 237 | 0.010 |
Why?
|
Alendronate | 1 | 1998 | 171 | 0.010 |
Why?
|
Lipid Peroxidation | 1 | 1997 | 270 | 0.010 |
Why?
|
Ovariectomy | 1 | 1998 | 661 | 0.010 |
Why?
|
Basement Membrane | 1 | 1996 | 357 | 0.010 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 1998 | 386 | 0.010 |
Why?
|
Peripheral Vascular Diseases | 1 | 1997 | 550 | 0.010 |
Why?
|
Bone Resorption | 1 | 1998 | 723 | 0.010 |
Why?
|
Family Practice | 1 | 1996 | 516 | 0.010 |
Why?
|
Proteinuria | 1 | 1996 | 658 | 0.010 |
Why?
|
Pregnancy | 2 | 1994 | 29144 | 0.010 |
Why?
|
Pregnanes | 1 | 1971 | 7 | 0.010 |
Why?
|
Amino Acids | 1 | 1998 | 1737 | 0.010 |
Why?
|
Carotid Artery Diseases | 1 | 1997 | 879 | 0.010 |
Why?
|
Retinal Vessels | 1 | 1996 | 772 | 0.010 |
Why?
|
Blood | 1 | 1971 | 598 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1997 | 6366 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 35425 | 0.000 |
Why?
|
Endothelium, Vascular | 1 | 1996 | 4459 | 0.000 |
Why?
|
Cost-Benefit Analysis | 1 | 1996 | 5388 | 0.000 |
Why?
|
Referral and Consultation | 1 | 1996 | 3531 | 0.000 |
Why?
|
Brain Ischemia | 1 | 1997 | 3265 | 0.000 |
Why?
|
Coronary Disease | 1 | 1997 | 6077 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1998 | 11486 | 0.000 |
Why?
|
Disease Progression | 1 | 1996 | 13286 | 0.000 |
Why?
|
Smoking | 1 | 1996 | 8987 | 0.000 |
Why?
|
Buffaloes | 1 | 1971 | 12 | 0.000 |
Why?
|
Estrus | 1 | 1971 | 81 | 0.000 |
Why?
|
Mice | 1 | 1998 | 81201 | 0.000 |
Why?
|
Blood Chemical Analysis | 1 | 1971 | 440 | 0.000 |
Why?
|
Animals | 2 | 1998 | 168768 | 0.000 |
Why?
|
Blood Coagulation | 1 | 1971 | 1127 | 0.000 |
Why?
|